Disodium fumarate
CAS 17013-01-3
Disodium fumarate (CAS 17013-01-3) is a pharmaceutical compound with 0 bioactivity targets and 49 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Disodium fumarate is linked to DTXSID10168802 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Disodium fumarate used for in pharmaceutical contexts?
Disodium fumarate (CAS 17013-01-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Disodium fumarate?
Disodium fumarate has 49 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal pain, Abdominal pain upper, Blood pressure diastolic decreased, Blood pressure systolic increased, Body temperature decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Disodium fumarate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Disodium Fumarate with EU status "permitted".
What clinical phase is Disodium fumarate in?
No phase 1-4 clinical development badge is rendered for Disodium fumarate because the matched compound identifier rows do not contain a max-phase value.